Clinical Trial Update: Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis

View source ↗

Summary

A completed clinical trial update examining cardiometabolic risk factors in individuals with multidrug-resistant tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Tuberculosis

Snippet

Sponsor: B.P. Koirala Institute of Health Sciences | Conditions: Tuberculosis (TB) | Status: COMPLETED